Literature DB >> 2997827

Morphine and delta 9-tetrahydrocannabinol: two-way cross tolerance for antinociceptive and heart-rate responses in the rat.

B Hine.   

Abstract

Tail-flick analgesic responses and heart-rate changes were measured in male Sprague-Dawley rats challenged with an acute IP morphine sulfate (MS) or delta 9-THC injection after receiving daily injections of delta 9-THC or morphine, respectively. Degree of tolerance development to each agent was determined before the cross-tolerance challenge was administered. Cross tolerance occurred to analgesic and bradycardic effects of a 10 mg/kg THC challenge in rats receiving 50 mg/kg MS injections over a 23-day period. Cross tolerance to the bradycardic effects of a 20 mg/kg MS challenge occurred in rats receiving seven daily 10 mg/kg delta 9-THC injections and to MS tail-flick analgesia after 14 days. Although rapid tolerance occurred during administration of both agents, cross tolerance to THC bradycardia occurred only in groups exhibiting complete tolerance to MS injections; cross tolerance to MS bradycardia was observed in animals that were only partially tolerant to THC injections. The data extend earlier cross tolerance data in the mouse to the rat, and provide new information using heart rate, a response that may mirror aversive internal states induced by drugs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2997827     DOI: 10.1007/bf00431774

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  16 in total

1.  Morphine-dependent rats: blockade of precipitated abstinence by tetrahydrocannabinol.

Authors:  B Hine; E Friedman; M Torrelio; S Gershon
Journal:  Science       Date:  1975-02-07       Impact factor: 47.728

2.  Delta9-tetrahydrocannabinol and some CNS depressants: evidence for cross-tolerance in the rat.

Authors:  L M Newman; M P Lutz; E F Domino
Journal:  Arch Int Pharmacodyn Ther       Date:  1974-02

3.  Opiate receptor: demonstration in nervous tissue.

Authors:  C B Pert; S H Snyder
Journal:  Science       Date:  1973-03-09       Impact factor: 47.728

4.  Tolerance to active constituents of marihuana.

Authors:  D E McMillan; R D Ford; J M Frankenheim; R A Harris; L S Harris
Journal:  Arch Int Pharmacodyn Ther       Date:  1972

5.  A comparison of some pharmacological actions of morphine and delta9-tetrahydrocannabinol in the mouse.

Authors:  A S Bloom; W L Dewey
Journal:  Psychopharmacology (Berl)       Date:  1978-05-31       Impact factor: 4.530

6.  Attenuation of precipitated abstinence in methadone-dependent rats by delta 9-THC.

Authors:  B Hine; M Torrelio; S Gershon
Journal:  Psychopharmacol Commun       Date:  1975

7.  Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(-)-delta9-tetrahydrocannabinol.

Authors:  R C Frederickson; C R Hewes; J W Aiken
Journal:  J Pharmacol Exp Ther       Date:  1976-11       Impact factor: 4.030

8.  Methadone-induced attenuation of the effects of delta 9-tetrahydrocannabinol on temporal discrimination in pigeons.

Authors:  S A Daniel; T Thompson
Journal:  J Pharmacol Exp Ther       Date:  1980-05       Impact factor: 4.030

9.  The attenuation of delta 9-tetrahydrocannabinol and morphine of the quasi-morphine withdrawal syndrome in rats.

Authors:  S G Zaluzny; G B Chesher; D M Jackson; R Malor
Journal:  Psychopharmacology (Berl)       Date:  1979-03-22       Impact factor: 4.530

10.  Effects of chronic delta 9-tetrahydrocannabinol administration on schedule-controlled behavior of pigeons: cross-tolerance to pentobarbital and barbital.

Authors:  L D Chait; M J Brocco; D E McMillan
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

View more
  6 in total

1.  Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors.

Authors:  Sandy Ghozland; Hans W D Matthes; Frederic Simonin; Dominique Filliol; Brigitte L Kieffer; Rafael Maldonado
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

Review 2.  Cannabinoid addiction: behavioral models and neural correlates.

Authors:  Rafael Maldonado; Fernando Rodríguez de Fonseca
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

Review 3.  Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings.

Authors:  Andrew J Kesner; David M Lovinger
Journal:  J Neurochem       Date:  2021-05-16       Impact factor: 5.546

4.  Mice expressing a "hyper-sensitive" form of the CB1 cannabinoid receptor (CB1) show modestly enhanced alcohol preference and consumption.

Authors:  David J Marcus; Angela N Henderson-Redmond; Maciej Gonek; Michael L Zee; Jill C Farnsworth; Randa A Amin; Mary-Jeanette Andrews; Brian J Davis; Ken Mackie; Daniel J Morgan
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

5.  Chronic cannabinoid exposure produces tolerance to the dopamine releasing effects of WIN 55,212-2 and heroin in adult male rats.

Authors:  Devan M Gomez; Thomas J Everett; Lindsey R Hamilton; Ajit Ranganath; Joseph F Cheer; Erik B Oleson
Journal:  Neuropharmacology       Date:  2020-10-25       Impact factor: 5.250

Review 6.  Cannabinoid Modulation of Dopamine Release During Motivation, Periodic Reinforcement, Exploratory Behavior, Habit Formation, and Attention.

Authors:  Erik B Oleson; Lindsey R Hamilton; Devan M Gomez
Journal:  Front Synaptic Neurosci       Date:  2021-06-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.